BlackRock Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$928K Buy
37,396
+440
+1% +$10K ﹤0.01% 1893
2016
Q3
$834K Buy
36,956
+3,876
+12% +$91.1K ﹤0.01% 1916
2016
Q2
$788K Buy
33,080
+1,418
+4% +$34K ﹤0.01% 1877
2016
Q1
$752K Buy
31,662
+1,929
+6% +$47.2K ﹤0.01% 1880
2015
Q4
$827K Sell
29,733
-14,176
-32% -$356K ﹤0.01% 1809
2015
Q3
$907K Sell
43,909
-1,037
-2% -$26.3K ﹤0.01% 1757
2015
Q2
$1.15M Buy
44,946
+4,480
+11% +$113K ﹤0.01% 1566
2015
Q1
$1.02M Buy
40,466
+6,153
+18% +$150K ﹤0.01% 1548
2014
Q4
$816K Sell
34,313
-1,678
-5% -$37.2K ﹤0.01% 1625
2014
Q3
$708K Sell
35,991
-602
-2% -$12.4K ﹤0.01% 1697
2014
Q2
$875K Sell
36,593
-321
-0.9% -$7.74K ﹤0.01% 1593
2014
Q1
$982K Buy
36,914
+1,649
+5% +$39.2K ﹤0.01% 1544
2013
Q4
$712K Buy
35,265
+10,131
+40% +$188K ﹤0.01% 1748
2013
Q3
$439K Buy
25,134
+322
+1% +$5.57K ﹤0.01% 2021
2013
Q2
$418K Buy
+24,812
New +$383K ﹤0.01% 1957

Other funds holding GMED

BlackRock Advisors's GMED Position: Q4 2016 in Review

BlackRock Advisors increased its Globus Medical (GMED) stake by 1.2% in Q4 2016, buying an estimated $10K and bringing the position to 37,396 shares worth $928K. The position accounts for ﹤0.01% of the portfolio, ranked #1893.

BlackRock Advisors first reported a position in GMED in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.15M in Q2 2015. 207 funds tracked by Wall St. Rank hold GMED as of Q4 2016.

  • BlackRock Advisors held 37,396 shares of Globus Medical worth $928K as of Q4 2016.
  • BlackRock Advisors bought 440 Globus Medical shares in Q4 2016, an estimated $10K.
  • Globus Medical made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1893 holding.
  • BlackRock Advisors first reported a position in Globus Medical in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Globus Medical position peaked at $1.15M in Q2 2015.
  • 207 funds tracked by Wall St. Rank held Globus Medical as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.